Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry

This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahiskali, Aileen S., Drekonja, Dimitri M., Alpern, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111177/
https://www.ncbi.nlm.nih.gov/pubmed/37067802
http://dx.doi.org/10.1001/jamanetworkopen.2023.8592
_version_ 1785027405946028032
author Ahiskali, Aileen S.
Drekonja, Dimitri M.
Alpern, Jonathan D.
author_facet Ahiskali, Aileen S.
Drekonja, Dimitri M.
Alpern, Jonathan D.
author_sort Ahiskali, Aileen S.
collection PubMed
description This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.
format Online
Article
Text
id pubmed-10111177
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-101111772023-04-19 Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry Ahiskali, Aileen S. Drekonja, Dimitri M. Alpern, Jonathan D. JAMA Netw Open Research Letter This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines. American Medical Association 2023-04-17 /pmc/articles/PMC10111177/ /pubmed/37067802 http://dx.doi.org/10.1001/jamanetworkopen.2023.8592 Text en Copyright 2023 Ahiskali AS et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Ahiskali, Aileen S.
Drekonja, Dimitri M.
Alpern, Jonathan D.
Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
title Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
title_full Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
title_fullStr Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
title_full_unstemmed Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
title_short Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
title_sort conflicts of interest among infectious diseases clinical practice guideline authors and the pharmaceutical industry
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111177/
https://www.ncbi.nlm.nih.gov/pubmed/37067802
http://dx.doi.org/10.1001/jamanetworkopen.2023.8592
work_keys_str_mv AT ahiskaliaileens conflictsofinterestamonginfectiousdiseasesclinicalpracticeguidelineauthorsandthepharmaceuticalindustry
AT drekonjadimitrim conflictsofinterestamonginfectiousdiseasesclinicalpracticeguidelineauthorsandthepharmaceuticalindustry
AT alpernjonathand conflictsofinterestamonginfectiousdiseasesclinicalpracticeguidelineauthorsandthepharmaceuticalindustry

Ejemplares similares